| |
| |
|
| Insider
Information: |
Mullen James C |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
227,563 |
|
|
Indirect Shares
|
75,000 |
|
|
| Direct
Value |
$29,809,992 |
|
|
|
Indirect Value
|
$16,870,500 |
|
|
| Total
Shares |
302,563 |
|
|
| Total
Value |
$46,680,492 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -18.6%
|
-115.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
CEO & President, Direc... |
2010-06-08 |
95,503 |
2010-06-08 |
75,000 |
Premium* |
|
|
Perkinelmer Inc |
PKI |
Director |
2014-11-14 |
45,551 |
2004-04-27 |
0 |
Premium* |
|
|
Patheon NV |
PTHN |
Chief Executive Office... |
2017-08-29 |
0 |
2017-08-29 |
0 |
Premium* |
|
|
Insulet Corp |
PODD |
Director |
2018-05-16 |
7,783 |
2017-08-09 |
0 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
CEO, Director |
2022-01-03 |
75,898 |
2018-05-18 |
0 |
Premium* |
|
|
Thermo Fisher Scientific |
TMO |
Director |
2024-05-22 |
2,828 |
2019-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
181 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2004-11-15 |
4 |
OE |
$16.90 |
$76,050 |
D/D |
4,500 |
21,175 |
|
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2004-11-22 |
4 |
OE |
$16.90 |
$76,050 |
D/D |
4,500 |
16,675 |
|
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2004-11-29 |
4 |
OE |
$16.90 |
$76,050 |
D/D |
4,500 |
12,175 |
|
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2004-12-02 |
4 |
OE |
$16.90 |
$16,900 |
D/D |
1,000 |
7,675 |
|
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2004-12-06 |
4 |
OE |
$16.90 |
$92,950 |
D/D |
5,500 |
6,675 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2004-05-14 |
4 |
B |
$18.33 |
$91,650 |
D/D |
5,000 |
9,020 |
2.39 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2010-11-04 |
4 |
OE |
$19.84 |
$198,400 |
D/D |
10,000 |
42,791 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2012-02-21 |
4 |
OE |
$19.87 |
$116,538 |
D/D |
5,865 |
42,200 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2004-04-27 |
4 |
A |
$19.91 |
$60,009 |
D/D |
3,014 |
4,020 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2014-02-07 |
4 |
OE |
$19.91 |
$288,768 |
D/D |
12,951 |
56,129 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2013-04-30 |
4 |
OE |
$21.67 |
$139,555 |
D/D |
6,440 |
46,355 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2010-11-04 |
4 |
AS |
$24.00 |
$240,000 |
D/D |
(10,000) |
32,791 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2014-11-14 |
4 |
OE |
$26.49 |
$235,549 |
D/D |
8,892 |
54,443 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2012-02-21 |
4 |
S |
$26.85 |
$157,481 |
D/D |
(5,865) |
36,335 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
CEO |
• • – |
2022-01-03 |
4 |
S |
$26.95 |
$491,979 |
D/D |
(18,252) |
75,898 |
0 |
% |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2013-04-30 |
4 |
S |
$30.31 |
$195,196 |
D/D |
(6,440) |
39,915 |
0 |
- |
|
| PTHN |
Patheon NV |
Chief Executive Officer |
• • – |
2017-08-29 |
4 |
D |
$35.00 |
$91,528,115 |
I/I |
(2,615,089) |
0 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-16 |
4 |
OE |
$35.42 |
$8,250,031 |
D/D |
229,877 |
255,129 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-17 |
4 |
OE |
$36.09 |
$2,530,739 |
D/D |
70,123 |
164,375 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-20 |
4 |
OE |
$36.09 |
$5,738,310 |
D/D |
159,000 |
253,252 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-27 |
4 |
OE |
$36.09 |
$451,125 |
D/D |
12,500 |
106,752 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-11 |
4 |
OE |
$37.45 |
$30,751,255 |
D/D |
745,750 |
882,250 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • – |
2018-05-18 |
4 |
B |
$38.03 |
$380,252 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| EDIT |
Editas Medicine, Inc. |
CEO |
• • – |
2021-10-18 |
4 |
S |
$38.03 |
$525,033 |
D/D |
(13,805) |
57,673 |
0 |
% |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2014-02-07 |
4 |
S |
$43.73 |
$566,334 |
D/D |
(12,951) |
43,178 |
0 |
- |
|
181 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
